• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部使用他莫昔芬治疗皮肤利什曼病。

Topical tamoxifen in the therapy of cutaneous leishmaniasis.

作者信息

Trinconi Cristiana T, Reimão Juliana Q, Bonano Vivian I, Espada Caroline R, Miguel Danilo C, Yokoyama-Yasunaka Jenicer K U, Uliana Silvia R B

机构信息

Departamento de Parasitologia,Instituto de Ciências Biomédicas, Universidade de São Paulo,Av. Prof. Lineu Prestes 1374,05508-000 São Paulo,Brazil.

出版信息

Parasitology. 2018 Apr;145(4):490-496. doi: 10.1017/S0031182017000130. Epub 2017 Mar 9.

DOI:10.1017/S0031182017000130
PMID:28274283
Abstract

The aims of the present work were to test the effect of tamoxifen administered topically and the therapeutic efficacy of tamoxifen and pentavalent antimonial combinations in an experimental model of cutaneous leishmaniasis. BALB/c mice infected with a luciferase expressing line of Leishmania amazonensis were treated with topical tamoxifen in two different formulations (ethanol or oil-free cream) as monotherapy or in co-administration with pentavalent antimonial. Treatment efficacy was evaluated by lesion size and parasite burden, quantified through luminescence, at the end of treatment and 4 weeks later. Topical tamoxifen, formulated in ethanol or as a cream, was shown to be effective. The interaction between tamoxifen and pentavalent antimonial was additive in vitro. Treatment with combined schemes containing tamoxifen and pentavalent antimonial was effective in reducing lesion size and parasite burden. Co-administration of tamoxifen and pentavalent antimonial was superior to monotherapy with antimonial.

摘要

本研究的目的是在皮肤利什曼病实验模型中测试局部应用他莫昔芬的效果以及他莫昔芬与五价锑联合用药的治疗效果。用表达荧光素酶的亚马逊利什曼原虫株感染的BALB/c小鼠,分别用两种不同剂型(乙醇或无油乳膏)的他莫昔芬进行单药治疗,或与五价锑联合给药。在治疗结束时及4周后,通过发光定量评估病变大小和寄生虫负荷,以此评价治疗效果。结果表明,以乙醇或乳膏形式配制的局部用他莫昔芬是有效的。他莫昔芬与五价锑在体外具有相加作用。含他莫昔芬和五价锑的联合方案治疗可有效减小病变大小并减轻寄生虫负荷。他莫昔芬与五价锑联合给药优于锑单药治疗。

相似文献

1
Topical tamoxifen in the therapy of cutaneous leishmaniasis.局部使用他莫昔芬治疗皮肤利什曼病。
Parasitology. 2018 Apr;145(4):490-496. doi: 10.1017/S0031182017000130. Epub 2017 Mar 9.
2
Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial.联合应用他莫昔芬和葡甲胺锑治疗皮肤利什曼病患者的随机试验。
Trop Med Int Health. 2018 Sep;23(9):936-942. doi: 10.1111/tmi.13119. Epub 2018 Jul 11.
3
The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.含硬脂胺脂质体包裹的葡甲胺锑酸盐对BALB/c小鼠皮肤利什曼病的活性
Exp Parasitol. 2019 May;200:30-35. doi: 10.1016/j.exppara.2019.03.004. Epub 2019 Mar 18.
4
A natural cell-penetrating nanopeptide combined with pentavalent antimonial as experimental therapy against cutaneous leishmaniasis.一种天然的细胞穿透纳米肽与五价锑联合作为治疗皮肤利什曼病的实验疗法。
Exp Parasitol. 2020 Oct;217:107934. doi: 10.1016/j.exppara.2020.107934. Epub 2020 Jul 19.
5
American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment.巴西皮肤利什曼病:全身性葡甲胺锑治疗的当前方法的批判性回顾及替代治疗的短期可能性
Trop Med Int Health. 2019 Apr;24(4):380-391. doi: 10.1111/tmi.13210. Epub 2019 Feb 19.
6
Efficacy of nanoemulsion with Pterodon emarginatus Vogel oleoresin for topical treatment of cutaneous leishmaniasis.边缘鳞斑鸠菊挥发油纳米乳剂经皮治疗皮肤利什曼病的疗效。
Biomed Pharmacother. 2021 Feb;134:111109. doi: 10.1016/j.biopha.2020.111109. Epub 2020 Dec 16.
7
The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis.米替福新与环氧化合物(环氧-α-拉帕醌和环氧甲基劳森)联合治疗增强了感染嗜酸性粒细胞白血病(嗜酸性粒细胞)亚马逊的小鼠的杀利什曼原虫效果。
Int J Parasitol Drugs Drug Resist. 2019 Aug;10:101-108. doi: 10.1016/j.ijpddr.2019.08.002. Epub 2019 Aug 12.
8
Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis.他莫昔芬与米替福新联合治疗亚马逊利什曼原虫感染小鼠模型皮肤利什曼病的疗效。
J Antimicrob Chemother. 2016 May;71(5):1314-22. doi: 10.1093/jac/dkv495. Epub 2016 Feb 6.
9
Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation.用于治疗皮肤利什曼病的局部葡聚糖胶体纳米载体:体外皮肤保留和体内评价。
Eur J Pharm Sci. 2020 Apr 30;147:105295. doi: 10.1016/j.ejps.2020.105295. Epub 2020 Mar 5.
10
The pentavalent antimonial therapy against experimental Leishmania amazonensis infection is more effective under the inhibition of the NF-κB pathway.在NF-κB通路受到抑制的情况下,五价锑疗法对实验性亚马逊利什曼原虫感染更有效。
Int Immunopharmacol. 2015 Sep;28(1):554-9. doi: 10.1016/j.intimp.2015.07.020. Epub 2015 Jul 25.

引用本文的文献

1
Compared Antileishmanial Activity of Clomiphene and Tamoxifen.克罗米芬与他莫昔芬的抗利什曼原虫活性比较
Biomedicines. 2024 Oct 9;12(10):2290. doi: 10.3390/biomedicines12102290.
2
Therapeutic effect of topical tamoxifen in murine cutaneous leishmaniasis caused by .局部使用他莫昔芬对由……引起的小鼠皮肤利什曼病的治疗效果。 (原文中“caused by”后面内容缺失)
Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0035824. doi: 10.1128/aac.00358-24. Epub 2024 Oct 24.
3
Potential Effects of Essential Oil from (Mart.) Kausel on : In Vivo, In Vitro, and In Silico Approaches.
(马丁)考塞尔的精油对……的潜在影响:体内、体外和计算机模拟方法 。 需注意,原文中“(Mart.) Kausel”和“: In Vivo, In Vitro, and In Silico Approaches.”前半部分信息不完整,推测这里可能是某种植物名称或研究对象未完整给出,以上译文是基于现有内容尽量准确翻译。
Microorganisms. 2024 Jan 19;12(1):207. doi: 10.3390/microorganisms12010207.
4
Design and Synthesis of New Anthranyl Phenylhydrazides: Antileishmanial Activity and Structure-Activity Relationship.新型蒽基苯肼的设计与合成:抗利什曼原虫活性及构效关系
Pharmaceuticals (Basel). 2023 Aug 9;16(8):1120. doi: 10.3390/ph16081120.
5
Development, Characterization, and In Vitro Biological Performance of Amphotericin B and Terbinafine Microemulsions Against Leishmania major.两性霉素 B 和特比萘芬微乳剂的研制、表征及其抗利什曼原虫的体外生物学性能。
Curr Microbiol. 2022 Nov 3;79(12):386. doi: 10.1007/s00284-022-03075-1.
6
Antileishmanial Activity of Tamoxifen by Targeting Sphingolipid Metabolism: A Review.通过靶向鞘脂代谢研究他莫昔芬的抗利什曼原虫活性:综述
Clin Pharmacol. 2022 Feb 21;14:11-17. doi: 10.2147/CPAA.S344268. eCollection 2022.
7
Tamoxifen Suppresses the Immune Response to ANKA and Exacerbates Symptomatology.他莫昔芬抑制对ANKA的免疫反应并加重症状表现。
Pathogens. 2021 Jun 12;10(6):743. doi: 10.3390/pathogens10060743.
8
Pharmacokinetics and pharmacodynamics in the treatment of cutaneous leishmaniasis - challenges and opportunities.皮肤利什曼病治疗中的药代动力学与药效学——挑战与机遇
RSC Med Chem. 2021 Jan 7;12(4):472-482. doi: 10.1039/d0md00343c.
9
Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis.纳米乳布替萘芬提高抗实验性皮肤利什曼病的疗效。
J Immunol Res. 2021 Mar 31;2021:8828750. doi: 10.1155/2021/8828750. eCollection 2021.
10
Microglia Inhibition Delays Retinal Degeneration Due to MerTK Phagocytosis Receptor Deficiency.小胶质细胞抑制因 MerTK 吞噬受体缺陷导致的视网膜变性。
Front Immunol. 2020 Jul 16;11:1463. doi: 10.3389/fimmu.2020.01463. eCollection 2020.